Neither from words, nor from visions: understanding p-medicine from innovative treatments

Authors

DOI:

https://doi.org/10.20416/lsrsps.v4i2.793

Keywords:

personalized medicine, precision medicine

Abstract

Despite its vagueness Personalized, Precision, P4, P5, individualized, stratified medicine—or p-medicine in short—has become an increasingly popular term in biomedical literature. Philosophers have attempted to analyze what these various terms involve and have discussed consequences for medical practices. In this article, I argue that an important question remains unaddressed:  what has made this project of p-medicine convincing to so many? My argument is that without real achievements, it would never have been. I also make the case that these achievements stem from the domain of monoclonal antibodies (mab), a new type of drug that justifies talks of personalized, precise, stratified, etc., medicine. In conclusion, while it may be possible to label any projection in the future of medicine as ‘p-medicine’, it is impossible to overlook mab-medicine as the spearhead.

Author Biography

  • Maël Lemoine, University of Tours

    Maître de Conférences à l'Université de Tours/ppINSERM U930/ppIHPST (Paris)

Downloads

Published

2018-03-27

Issue

Section

Contemporary issues in personalized medicine

How to Cite

“Neither from Words, nor from Visions: Understanding P-Medicine from Innovative Treatments”. 2018. Lato Sensu: Revue de la Société de Philosophie Des Sciences 4 (2). https://doi.org/10.20416/lsrsps.v4i2.793.

Most read articles by the same author(s)